Click Here for 5% Off Your First Aladdin Purchase!

Etoricoxib - ≥98.0%, high purity , Cyclooxygenase-2 inhibitor, CAS No.202409-33-4, Cyclooxygenase-2 inhibitor

  • Moligand™
  • ≥98%
Item Number
E126660
Grouped product items
SKUSizeAvailabilityPrice Qty
E126660-10mg
10mg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$64.90
E126660-50mg
50mg
In stock
$129.90
E126660-250mg
250mg
In stock
$585.90
E126660-1g
1g
In stock
$2,106.90
E126660-5g
5g
In stock
$9,477.90
View related series
COX-2 Inhibitor

Basic Description

SynonymsEtoricoxib|202409-33-4|Arcoxia|Tauxib|Nucoxia|Algix|MK-0663|5-Chloro-6'-methyl-3-(4-(methylsulfonyl)phenyl)-2,3'-bipyridine|MK-663|L-791456|MK 0663|2,3'-Bipyridine, 5-chloro-6'-methyl-3-[4-(methylsulfonyl)phenyl]-|5-chloro-6'-methyl-3-[4-(methylsulfonyl)p
Specifications & PurityMoligand™, ≥98%
Biochemical and Physiological MechanismsEtoricoxib is a specific inhibitor of COX-2(Cyclooxygenase-2)
Storage TempStore at 2-8°C,Argon charged
Shipped InWet ice
GradeMoligand™
Action TypeINHIBITOR
Mechanism of actionCyclooxygenase-2 inhibitor
Note10mg售完停产,不再备货
Product Description

EtoricoxibEtoricoxib(MK-0663) selectively inhibited COX-2 in human whole blood assays in vitro, with an IC50 value of1.1 ± 0.1 μM for COX-2 (LPS-induced prostaglandin E2 synthesis), compared with an IC50 value of 116 ± 8 μM for COX-1 (serum thromboxane B2 generation after clotting of the blood).
A specific inhibitor of COX-2.

Product Properties

ALogP3.3

Names and Identifiers

IUPAC Name 5-chloro-2-(6-methylpyridin-3-yl)-3-(4-methylsulfonylphenyl)pyridine
INCHI InChI=1S/C18H15ClN2O2S/c1-12-3-4-14(10-20-12)18-17(9-15(19)11-21-18)13-5-7-16(8-6-13)24(2,22)23/h3-11H,1-2H3
InChi Key MNJVRJDLRVPLFE-UHFFFAOYSA-N
Canonical SMILES CC1=NC=C(C=C1)C2=C(C=C(C=N2)Cl)C3=CC=C(C=C3)S(=O)(=O)C
Isomeric SMILES CC1=NC=C(C=C1)C2=C(C=C(C=N2)Cl)C3=CC=C(C=C3)S(=O)(=O)C
WGK Germany 3
PubChem CID 123619
Molecular Weight 358.84
Beilstein 8073797

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section

9 results found

Lot NumberCertificate TypeDateItem
J22111016Certificate of AnalysisJul 16, 2024 E126660
J22111017Certificate of AnalysisJul 16, 2024 E126660
J22111018Certificate of AnalysisJul 16, 2024 E126660
J22111019Certificate of AnalysisJul 16, 2024 E126660
K2129523Certificate of AnalysisSep 21, 2023 E126660
K2129631Certificate of AnalysisSep 21, 2023 E126660
H2004042Certificate of AnalysisJun 14, 2022 E126660
H2004041Certificate of AnalysisJun 14, 2022 E126660
H2004040Certificate of AnalysisJun 14, 2022 E126660

Chemical and Physical Properties

SolubilitySoluble in DMSO, and methanol

Safety and Hazards(GHS)

Pictogram(s) GHS06
Signal Danger
Hazard Statements

H302:Harmful if swallowed

H310:Fatal in contact with skin

Precautionary Statements

P280:Wear protective gloves/protective clothing/eye protection/face protection.

P310:Immediately call a POISON CENTER or doctor/physician.

P302+P350:IF ON SKIN: Gently wash with plenty of soap and water.

WGK Germany 3

Related Documents

References

1. Wang R.  (2021)  Etoricoxib may inhibit cytokine storm to treat COVID-19..  Med Hypotheses,  150  (3): (110557).  [PMID:33730601]

Solution Calculators